SOCIETY FOR INHERITED METABOLIC DISORDERS


Annual Meeting: March 9 - 12, 2014
Asilomar Conference Center, Pacific Grove, California

POSTER PRESENTATION

Posters will be displayed on 3'10" x 3'10" (46 inches x 46 inches, 116.8 cm x 116.8 cm) boards.

Posters may be mounted starting on Monday 10 March, 2014 at 08:00, and will remain posted throughout the meeting.
Posters must be removed after the coffee break on Wenesday. 12 March, 2014.

Board #
Board # First Author Title of Abstract
1 SIMD BUSINESS
2 SIMD BUSINESS
3 Prasun, Pankaj COMBINED D-2 AND L-2 HYDROXYGLUTARIC ACIDURIA PRESENTING WITH FACIAL DYSMORPHISM AND MULTIPLE MALFORMATIONS
4 Lam, Christina Two novel compound heterozygous mutations in OPA3 in two siblings with 3-methylglutaconic aciduria Type III
5 Ghaloul-Gonzalez, Lina HYPERAMMONIEMIC ENCEPHALOPATY AND OROTIC ACIDURIA MIMICKING ORNITHINE TRANSCARBAMOYLASE (OTC) DEFICIENCY, A CONSISTENT PHENOTYPE IN A SUBSET OF PATIENTS WITH HEPATOCELLULAR CARCINOMA.
6 Brown, Donna MATERNAL METHYLMALONIC ACIDEMIA (MMA) IN PREGNANCY
7 Stiles, A.R. BIOCHEMICAL, MOLECULAR, AND CLINICAL CHARACTERISTICS IN THE THIRD PATIENT REPORTED WITH 2-KETOADIPIC ACIDURIA CAUSED BY MUTATIONS IN DHTKD1
8 Deeb, Kristin K. SOMATIC MOSAICISM FOR A NOVEL PDHA1 MUTATION IN A MALE WITH SEVERE PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY: CASE REPORT AND LITERATURE REVIEW
9 Celeste, Frank GNE GENE MUTATIONS ASSOCIATED WITH GNE MYOPATHY
10 Bellesheim, K.R. ATYPICAL WORKING MEMORY-RELATED NEURAL ACTIVITY IN INDIVIDUALS WITH PHENYLKETONURIA
11 Mohamed, Miski WHOLE EXOME SEQUENCING IN METABOLIC CUTIS LAXA
12 Ayyub, Omar
TRAVEL AWARD WINNER
(See abstract under Travel awards)
RAPID POINT OF CARE DETECTION OF HYPERAMMONEMIA IN WHOLE BLOOD
13 Gangoiti, J.A. A COMPOSITE METHOD WITH THE POTENTIAL OF UNIVERSAL BIOCHEMICAL GENETICS ANALYSIS BY USING A SINGLE-COLUMN
14 Atwal, P.S. Biomarkers For Evidence of Mitochondrial Dysfunction In Cobalamin C Disease
15 Christ, Shawn E. MORPHOMETRIC ANALYSIS OF GRAY MATTER INTEGRITY IN INDIVIDUALS WITH PKU
16 Wilnari, Yael PRENATAL TREATMENT OF ORNITHINE TRANSCARBAMYLASE DEFICIENCY
17 Belmont-Martinez, Leticia ORAL MANIFESTATIONS IN PATIENTS WITH CYSTINOSIS
18 Burgard, Peter BEHAVIORAL AND EMOTIONAL PROBLEMS AND QUALITY OF LIFE IN PATIENTS WITH ORGANIC ACIDEMIAS AND UREA CYCLE DISORDERS – RESULTS FROM THE EIMD
19 Yasuda, Makiko Acute Hepatic Porphyrias: Inhibition of Hepatic ALAS1 with an RNAi Therapeutic Provides Effective Prevention and Treatment of Induced Acute Attacks in Acute Intermittent Porphyria Mice
20 Boles, Richard G. TIRED, HURTING, AND QUEASY: MUTATIONS IN THE MITOCHONDRIAL CHAPERONE TRAP1 ARE ASSOCIATED WITH COMMON FUNCTIONAL SYMPTOMATOLOGY AND ARE A NOVEL CAUSE OF POLYGENIC MITOCHONDRIAL DISEASE
21 MacLeod, Erin PREDICTING NITROGEN BALANCE DURING ACUTE METABOLIC DECOMPENSATION USING A COMPUTATIONAL MODEL OF METABOLISM
22 MacLeod, Erin RESTING METABOLIC RATE IN INDIVIDUALS WITH INBORN ERRORS OF METABOLISM DURING ILLNESS MAY NOT BE INCREASED COMPARED TO THEIR HEALTHY REQUIREMENTS.
23 Ullal, Anirudh J. DRIED BLOOD SPOT ENZYMATIC ASSAYS FOR MPS TYPE IVA (MORQUIO) AND TYPE VI (MAROTEAUX-LAMY) SYNDROMES
24 Levy, Paul A. THE USE OF TOTAL PARENTERAL NUTRITION (TPN) FOR A PROTEIN CHALLENGE IN PATIENTS WITH METHYLMALONIC ACIDURIA.
25 Falk, Marni, J. (+) EPICATECHIN THERAPY HAS BENEFICIAL EFFECTS IN HUMAN CELL AND C. elegans MODELS OF PRIMARY MITOCHONDRIAL RESPIRATORY CHAIN DISEASE
26 Tarasenko, Tatiana N. HEPATIC MITOCHONRIAL ADAPTATIONS DURING SYSTEMIC IMMUNE ACTIVATION: IMPLICATIONS FOR INBORN ERRORS OF METABOLISM
27 Linares, Ricardo A. CLINICAL AND GENETIC ASSESSMENT OF A PATIENT PRESENTING WITH GENERALIZED CHOREA FROM THE NIH UNDIAGNOSED DISEASES PROGRAM (UDP)
28 Ellsworth, Katazyna
TRAVEL AWARD WINNER
(See abstract under Travel awards)
QUANTIFICATION OF URINE KERATAN SULFATE LEVELS IN MUCOLIPIDOSIS II AND III PATIENTS BY UPLC-MS/MS
29 Niemi, Anna-Kaisa HAWKINSINURIA PRESENTING AS FAILURE TO THRIVE, METABOLIC ACIDOSIS, HEMOLYTIC ANEMIA AND PYROGLUTAMIC ACIDURIA IN FRATERNAL TWINS
30 Niemi, Anna-Kaisa MITOCHONDRIAL COMPLEX CARE CLINIC MODEL – EMPOWERING FAMILIES AS PART OF THE CARE TEAM
31 Studinski, April L. IMPROVING THE DIAGNOSTIC CHALLENGES OF MUCOPOLYSACCHARIDOSES
32 Coughlin II, Curtis R. COPY NUMBER LOSS PROXIMAL TO THE CODING REGION OF THE ORNITHINE TRANSCARBAMYLASE (OTC) GENE CONFERS SEVERE NEONATAL OTC DEFICIENCY (OTCD): THE FIRST REPORT THAT A DISTANT MUTATION CAN CONFER OTCD
33 McClure, Julie HOMOCYSTEINEMIA DUE TO MTHFR DEFICIENCY IN A YOUNG ADULT PRESENTING WITH BILATERAL LENS DISLOCATION
34 Conway, Robert L. A CASE OF MATERNAL METHIONINE ADENOSYLTRANSFERASE DEFICIENCY WITH MILD NEUROLOGIC CLINICAL FEATURES FINDINGS IDENTIFIED THROUGH NEWBORN SCREENING
35 Hasadsri, Linda
TRAVEL AWARD WINNER
(See abstract under Travel awards)
DIAGNOSIS OF PRIMARY HYPEROXALURIA TYPE III, A NOVEL DISORDER OF HYDROXYPROLINE METABOLISM, BY GC-MS ANALYSIS OF URINE
36 Vats, Divya BIOTIN RESPONSIVE HOLOCABOXYLASE SYNTHASE DETECTED BY ISOLATED ELEVATION OF C3 AND C5-OH ON NEWBORN SCREEN
37 Sremba, Leighann CONGENITAL MUSCULAR DYSTROPY IN THE METBOLIC CLINIC
38 Shepard, Peter J. RUNS OF HOMOZYGOSITY ASSOCIATED WITH PHENOTYPIC EXPRESSION IN CASES OF 3-MCC DEFICIENCY.
39 Andersson, H.C. EVALUATION OF BEHAVIOR, EXECUTIVE FUNCTION, NEUROTRANSMITTER FUNCTION AND GENOMIC EXPRESSION IN PKU "NONRESPONDERS" TO SAPROPTERIN
40 Adams, David R. COMPLEX PRESENTATION OF 2-METHYL-3-HYDROXYBUTRYL-CoA-DEHYDROGENASE (MHBD) DEFICIENCY, STEROID SULFATASE DEFICIENCY AND MULTIPLE CHROMOSOMAL DEFECTS
41 Sparks, Susan E. FKRP MUTATIONS RESULT IN DEFECTIVE GLYCOSYLATION AND A MUSCULAR DYSTROPHY PHENOTYPE
42 Freehauf, Cynthia L. FIRST REPORT OF PRENATAL HYDROXOCOBALAMIN (VITAMIN B12) THERAPY IN cblA CLASS METHYLMALONIC ACIDEMIA
43 Wang, Lili GENE THERAPY FOR UREA CYCLE DISORDERS: CHARACTERIZATION AND RESCUE OF THE ORNITHINE TRANSCARBAMYLASE KNOCKOUT MOUSE
44 Goldstein, Amy INDIRECT CALORIMETRY ESTIMATES OF FAT OXIDATION ARE CORRELATED WITH AGE AT PRESENTATION OF LONG-CHAIN FATTY ACID OXIDATION DISORDER
45 Ng, Bobby G. MUTATIONS IN CAD IMPAIR DE NOVO PYRIMIDINE BIOSYNTHESIS AND DECREASE GLYCOSYLATION PRECURSORS
46 El-Hattab, Ayman W. GLUCOSE METABOLISM DERANGEMENTS IN ADULTS WITH THE MELAS MUTATION M.3243A>G
47 Morton, D. Holmes CARDIOMYOPATHY IS COMMON IN THE PROPIONIC ACIDEMIA VARIANT PCCB c.1606a>g AND CAN BE PREVENTED AND REVERSED BY METABOLIC THERAPY.
48 Anikster, Yair INHERITED GLYCOSYL PHOSPHATIDYLINOSITOL DEFICIENCY DUE TO A MUTATION IN PIGM CAUSES PORTAL VEIN THROMBOSIS AND ABSENCE SEIZURES
49 Morizono, Hiroki WHY IS N-ACETYLGLUTAMATE DEFICIENCY SO RARE?
50 Vladutiu, R. INBORN ERRORS OF MUSCLE METABOLISM IMPLICATED IN RISK FOR STATIN-INDUCED MYOPATHY.
51 Wolfe, Lynne A. FAILURE TO THRIVE IN CHILDREN WITH MITOCHONDRIAL DISEASES
52 Lourenco, Charles Marques
TRAVEL AWARD WINNER
(See abstract under Travel awards)
UNRAVELING A NEUROMETABOLIC HEREDITARY SPASTIC PARAPLEGIA: B4GALNT1 DEFICIENCY AS NEW INBORN ERROR OF METABOLISM AFFECTING GLYCOSPHINGOLIPID BIOSYNTHESIS
53 Caldovic, Ljubica AMP-DEPENDENT PROTEIN KINASE REGULATES UREA CYCLE GENES IN RESPONSE TO DIETARY PROTEIN INTAKE
54 Hasadsri, Linda A NOVEL ARYLSULFATASE B MUTATION IN A PATIENT WITH MUCOPOLYSACCHARIDOSIS TYPE VI MISDIAGNOSED AS AUSTIN SYNDROME
55 Haberle, Johannes NATURAL COURSE OF 63 NEONATAL ONSET UREA CYCLE DEFECT PATIENTS IN THE YEARS 2001-2013
56 Bartley, James A SITE-SPECIFIC POST-ANALYTICAL TOOL OF THE REGION 4 STORK (R4S) IMPROVES THE EVALUATION OF PROXIMAL UREA CYCLE DISORDERS FOR INFANTS WHOSE CITRULLINE IS ≤5 μmol/L ON CALIFORNIA NEWBORN SCREENING.
57 Alhariri, Ahmad GAUCHER DISEASE AND LANGERHANS CELL HISTIOCYTOSIS
58 Enns, Gregory M. CORRELATION OF GLUTATHIONE REDOX POTENTIAL WITH MITOCHONDRIAL DISEASE ETIOLOGY AND CLINICAL SEVERITY
59 Coldwell, James MEDIUM CHAIN ACYL-CoA-DEHYDROGENASE DEFICIENCY IN THE NEWBORN: A TALE OF TWO SISTERS
60 Dieter, Brady R. CHARACTERIZATION OF GLB1 cDNA FROM NORMAL AND GM1-GANGLIOSIDOSIS AFFECTED OVINE FIBROBLASTS TO CONFIRM A POSSIBLE DISEASE-CAUSING MUTATION
61 Rose, Shannon
TRAVEL AWARD WINNER
(See abstract under Travel awards)
OXIDATIVE STRESS INDUCES MITOCHONDRIAL DYSFUNCTION IN AUTISM CELL LINES
62 Longo, Nicola ANAPLEROTIC THERAPY IN  PROPIONIC ACIDEMIA
63 Gropman, Andrea REDUCED FRONTO-PARIETAL FUNCTIONAL CONNECTIVITY IN ORNITHINE TRANSCARBAMYLASE DEFICIENCY
64 Matern, Dietrich Measurement of psychosine in dried blood spots – A possible improvement of newborn screening for Krabbe disease.
65 Matern, D. Newborn screening for Lysosomal Storage Disorders, Friedreich Ataxia, Wilson disease and X-Adrenoleukodystrophy. A comparative effectiveness study.
66 Matern, Dietrich The (surprising) prevalence of 12 lysosomal storage disorders, Friedreich Ataxia, Wilson disease and X-Adrenoleukodystrophy in California.
67 Williams, M. CITRATE TRANSPORTER DEFICIENCY IN A PREMATURE-GROWTH-RESTRICTED NEWBORN WITH RESPIRATORY INSUFFICIENCY, GROSS INCIDENTS AND PERSISTENT LACTIC ACIDOSIS.
68 McCormack, Shana, E. TRANSCRIPTIONAL CORRELATES OF LINEAR GROWTH AND LIPID HOMEOSTASIS IN INDIVIDUALS WITH MITOCHONDRIAL RESPIRATORY CHAIN DISEASE
69 Sahai, I. LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS: EIGHT YEAR EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM
70 Woontner, Michael CORRELATING ENZYME ACTIVITY AND GENOTYPE OF VERY LONG-CHAIN Acyl-CoA DEHYDROGENASE
71 Wood, Philip A. PURSUING “DISEASE IN A DISH” MODELING OF HUMAN MITOCHONDRIAL FATTY ACID OXIDATION DEFICIENCY DISEASES
72 Venturoni, Leah DEEP SEQUENCING OF GCDH IN KNOWN GLUTARIC ACIDEMIA TYPE 1 PATIENTS
73 Vela-Amieva, M. NEONATAL ACUTE SEVERE ONSET INBORN ERRORS OF INTERMEDIARY METABOLISM IN NEONATAL INTENSIVE CARE UNITS AND EMERGENCY WARDS IN MEXICO
74 Harding, Cary O. PHARMACOLOGIC INHIBITION OF L-TYROSINE DEGRADATION AMELIORATES CEREBRAL DOPAMINE DEFICIENCY IN MURINE PHENYLKETONURIA (PKU)
75 Winn, Shelley R. SAPROPTERIN DIHYDROCHLORIDE THERAPY RESTORES BRAIN MONOAMINE NEUROTRANSMITTER CONTENT IN MURINE PHENYLKETONURIA (PKU)
76 Langaee, Taimour HAPLOTYPE VARIATIONS INFLUENCE HUMAN GSTZ1 GENE EXPRESSION AND THE KINETICS OF THE ANTI-TUMOR DRUG DICHLOROACETATE (DCA)
77 Stuy, M. REFEEDING SYNDROME (RFS) ACCOMPANIED BY HYPERAMMONEMIA IN A YOUNG WOMAN WITH ARGINOSUCCINATE LYASE (ASL) DEFICIENCY
78 Morava, Eva DEFINING MAN1B1 DEFICIENCY, A NOVEL GLYCOSYLATION DISORDER LEADING TO INTELLLECTUAL DISABILITY, TRUNCAL OBESITY AND A UNIQUE GLYCOSYLATION PATTERN
79 Tim-aroon, Thipwimol
TRAVEL AWARD WINNER
(See abstract under Travel awards)
HOLDING PARENTERAL NUTRITION FOR 3 HOURS BEFORE NEWBORN SCREENING MARKEDLY REDUCES FALSE POSITIVE AMINO ACID RESULTS
80 Grange, Dorothy K. MISSOURI’S EXPERIENCE WITH FULL POPULATION PILOT NEWBORN SCREENING FOR POMPE, GAUCHER, FABRY AND HURLER DISORDERS USING DIGITAL MICROFLUIDICS METHODOLOGY
81 Manoli, I. CRITICAL REAPPRAISAL OF MEDICAL FOODS UTILIZATION IN METHYLMALONIC ACIDEMIA
82 Mercimek-Mahmutoglu, S THIRTEEN NEW PATIENTS WITH GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY AND FUNCTIONAL CHARACTERIZATION OF NINETEEN MISSENSE VARIANTS IN THE GAMT GENE
83 Mercimek-Mahmutoglu, S RETROSPECTIVE REVIEW OF CEREBROSPINAL FLUID CATECHOLAMINE AND SEROTONIN METABOLITES FOR INDICATIONS AND DIAGNOSIS OF NEUROTRANSMITTER DISORDERS
84 Shchelochkov, Oleg A. ASSESSMENT OF BARRIERS TO DRUG ADHERENCE IN THE TREATMENT OF UREA CYCLE DISORDERS IN NORTH AMERICA
85 Turgeon, Raymond K. CHOLESTANE-3β, 5α, 6β-TRIOL ANALYSIS IN DRIED BLOODS SPOTS FOR THE EVALUATION OF NIEMANN-PICK TYPE C DISEASE
86 Suormala, Jusufi CHARACTERIZATION OF FUNCTIONAL DOMAINS OF MMADHC, A PROTEIN RESPONSIBLE FOR INTRACELLULAR COBALAMIN PROCESSING
87 Muenzer, Joseph INVESTIGATIONAL INTRATHECAL ENZYME REPLACEMENT THERAPY FOR CHILDREN WITH THE SEVERE FORM OF HUNTER SYNDROME (MUCOPOLYSACCHARIDOSIS II)
88 Camp, Kathryn M. PHENYLKETONURIA SCIENTIFIC REVIEW CONFERENCE: FINDINGS AND RESEARCH AGENDA
89 Zhu, Alyssa OPHTHALMOLOGIC FINDINGS IN PRIMARY MITOCHONDRIAL DISEASE
90 Merritt, J. Lawrence A RATIONALE FOR NEWBORN SCREENING FOR PROXIMAL UREA CYCLE DISORDERS
91 Merritt, J. Lawrence ETHICAL RATIONALE FOR RECONSIDERING NEWBORN SCREENING FOR PROXIMAL UREA CYCLE DISORDERS
92 El-Gharbawy, Areeg OPTIMIZING METABOLIC CONTROL OF GLYCOGEN STORAGE DISEASE TYPE 3 (GSD3): POTENTIAL ROLE FOR MEDIUM CHAIN TRIGLYCERIDES (MCT)
93 Jay, Allison URINARY SULFATIDE andCERAMIDE TRIHEXOSIDES ANALYSIS BY LC-MS/MS AND POST-ANALYTICAL INTERPRETRATION EMPLOYING THE COLLABORATIVE LABORATORY INTEGRATED REPORTS (CLIR) SOFTWARE.
94 De Jesus, Victor R. ASSURING QUALITY OF NEWBORN SCREENING DRIED-BLOOD SPOT ASSAYS WORLDWIDE: THE CDC’S NEWBORN SCREENING QUALITY ASSURANCE PROGRAM
95 De Jesus, Victor R. A SIMPLE ASSAY TO EXAMINE AMINO ACID AND PROTEIN CONTENT OF HUMAN BREAST MILK, HOMOGENIZED BOVINE WHOLE MILK, AND INFANT FORMULAS
96 Hauser, Natalie 3-HYDROXYISOBUTYRIC ACIDURIA: PATIENT DESCRIPTION AND BIOCHEMICAL ABNORMALITIES
97 Wang, Fang IDH2(R140Q) KNOCK-IN MOUSE RECAPITULATING HUMAN TYPE II D-2-HYDROXYGLUTARIC ACIDURIA
98 Frye, Richard E. TREATABLE METABOLIC DISORDERS ASSOCIATED WITH AUTISM SPECTRUM DISORDER
99 Nagamani, S.C. TREATMENT-RELATED SIGNS AND SYMPTOMS AMONG PATIENTS WITH UREA CYCLE DISORDERS (UCD’S) DURING TREATMENT WITH SODIUM PHENYLBUTYRATE (NaPBA) AND GLYCEROL PHENYLBUTYRATE (GPB)
100 Ahring, Kirsten OBESITY AND OVERWEIGHT IN PKU: THE RESULTS FROM 9 CENTRES IN EUROPE AND TURKEY
101 Belanger-Quintana, A. MULTICENTER STUDY ON GROWTH IN PKU PATIENTS: PRELIMINARY RESULTS
102 Khuchua, Zaza CARDIAC METABOLIC PATHWAYS AFFECTED IN MOUSE MODEL OF BARTH SYNDROME
103 Strauss, Arnold STRESS-INDUCED LETHALITY IN CARDIAC-SPECIFIC VLCAD KNOCKOUT MICE
104 Ney, Denise SKELETAL FRAGILITY AND RENAL IMPAIRMENT IN PHENYLKETONURIA: INSIGHTS FROM PAHenu2MICE
105 Estrada-Veras, Juvianee CEREBELLAR HYPOMETABOLISM IN ERDHEIM CHESTER DISEASE: HISTIOCYTIC INFILTRATION, EARLY NEURODEGENERATION OR UNDERLYING METABOLIC DEFICIT?
106 Pallone, Nicole CASE REVIEW OF RP: TREATING PKU PATIENTS UNDER 4 YEARS OLD WITH SAPROPTERIN
107 Cingi, Elif PRE PROCEDURAL MIDAZOLAM ADMINISTRATION SAFETY AND EFFICACY FOR SAN FILIPPO A SYNDROME PATIENTS
108 Chagnon, S. PYRIDOXYL 5 PHOSPHATE DEFICIENCY IN A PATIENT WITH MITOCHONDRIAL DEPLETION SYNDROME AND LEIGH DISEASE DUE TO SUCLG1 MUTATIONS: A TREATABLE CO-MORBIDITY
109 Huizing, Marjan SIALYLATION OF THOMSEN-FRIEDENREICH ANTIGEN IS A NONINVASIVE BLOOD-BASED BIOMARKER FOR GNE MYOPATHY
110 Smith, Laurie D. WHOLE GENOME SEQUENCING AS A DIAGNOSTIC TOOL IN A PRESUMED INBORN ERROR OF METABOLISM
111 Yano, S. INCORPORATING NEUROTRANSMITTER METABOLITES MELATONIN AND DOPAMINE FOR OPTIMIZING DIETARY MANAGEMENT OF PHENYLKETONURIA: TRYPTOPHAN SUPPLEMENTATION ALONE DOES NOT IMPROVE SEROTONIN METABOLISM
112 Raile, Klemens PTERIN-4A-CARBINOLAMINE DEHYDRATASE DEFICIENCY: FROM NEONATAL HYPERPHENYLALANINEMIA TO EARLY-ONSET DIABETES
113 Naviaus, Robert K. PURINERGIC SIGNALING AND THE CELL DANGER RESPONSE—NEW TOOLS FOR UNDERSTANDING THE BEHAVIORAL FEATURES OF PURINE AND PYRIMIDINE DISORDERS
114 Wang, Y FUNCTIONAL AND PHYSICAL MAPPING OF THE ARCHITECTURE OF MITOCHONDRIAL ENERGY METABOLISM
115 Frazier, Dianne NEED FOR EVIDENCE-BASED RESEARCH TO ASSESS BENEFITS OF NUTRITION TREATMENTS FOR RARE INBORN ERRORS OF METABOLISM
116 Blau, Nenad IEMBASE, A KNOWLEDGEBASE OF INBORN ERRORS OF METABOLISM
117 Wettstein, Sarah LINKING GENOTYPES AND LOCUS-SPECIFIC DATABASES WITH TOOLS FOR PREDICTION OF PHENOTYPE AND TETRAHYDROBIOPTERIN-RESPONSIVENESS IN PHENYLKETONURIA
118 Gillis, L.J. MOLECULAR, BIOCHEMICAL AND CLINICAL HETEROGENEITY IN VERY-LONG-CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY: THE CANADIAN ATLANTIC MARITIME PROVINCES NEWBORN SCREENING EXPERIENCE
119 Van Calcar, Sandra C. DEVELOPMENTAL OUTCOMES OF SHORT-BRANCHED CHAIN ACYL-CoA DEHYDROGENASE DEFICIENCY (SBCADD) IN THE HMONG-AMERICAN POPULATION:RESULTS FROM A PROSPECTIVE COHORT STUDY IN WISCONSIN
120 Minkler, Paul E. RAPID, COMPREHENSIVE, SELECTIVE, ACCURATE, AND PRECISE QUANTIFICATION OF ACYLCARNITINES AND ACYL-CoAs IN TISSUES USING ON-LINE ION-EXCHANGE TRAPPING AND UHPLC-MS/MS
121 Deschenes, E. ASSESSMENTS OF EXECUTIVE FUNCTION PERFORMANCE BEFORE AND AFTER SAPROPTERIN TREATMENT IN PATIENTS WITH PHENYLKEONURIA
122 Kimonis, Virginia VARIABLE CLINICAL FEATURES IN 13 PATIENTS WITH POMPE DISEASE 
123 Pfeil, Johannes NEWBORN SCREENING BY TANDEM MASS SPECTROMETRY FOR GLUTARIC ACIDURIA TYPE 1: A COST-EFFECTIVENESS ANALYSIS


Return